Circio Holding ASA

OB:CRNA Stock Report

Market Cap: NOK 32.2m

Circio Holding Future Growth

Future criteria checks 5/6

Circio Holding is forecast to grow earnings and revenue by 61.2% and 110.5% per annum respectively while EPS is expected to decline by 140.2% per annum.

Key information

61.2%

Earnings growth rate

-140.2%

EPS growth rate

Biotechs earnings growth16.8%
Revenue growth rate110.5%
Future return on equityn/a
Analyst coverage

Low

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

May 29
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Aug 24
Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Jul 08
Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Oct 27
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Is Targovax (OB:TRVX) A Risky Investment?

Jul 05
Is Targovax (OB:TRVX) A Risky Investment?

Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Mar 10
Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Feb 20
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

Dec 05
The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

Earnings and Revenue Growth Forecasts

OB:CRNA - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202614481N/A811
12/31/202561-418-42
12/31/2024N/A1817182
6/30/202409-49-49N/A
3/31/20240-51-69-69N/A
12/31/20230-111-89-89N/A
9/30/202310-446-103-98N/A
6/30/202310-449-115-110N/A
3/31/202310-440-112-107N/A
12/31/202210-433-114-109N/A
9/30/2022N/A-107-105-105N/A
6/30/2022N/A-110-94-94N/A
3/31/2022N/A-106-91-91N/A
12/31/2021N/A-98-85-85N/A
9/30/2021N/A-98-87-87N/A
6/30/20210-97-94-94N/A
3/31/20210-105-100-100N/A
12/31/20201-108-111-111N/A
9/30/20203-117-122-122N/A
6/30/20203-120-128-128N/A
3/31/20203-132-134-134N/A
12/31/20192-148-143-143N/A
9/30/20190-153-135-135N/A
6/30/20190-162-132-132N/A
3/31/20190-153-125-125N/A
12/31/20180-147-112-112N/A
9/30/20180-139-111-111N/A
6/30/20180-132-108-108N/A
3/31/20180-129N/A-112N/A
12/31/20170-122N/A-107N/A
9/30/20170-121N/A-106N/A
6/30/20170-119N/A-102N/A
3/31/20170-118N/A-104N/A
12/31/20160-122N/A-109N/A
9/30/20160-134N/A-120N/A
6/30/20160-137N/A-129N/A
3/31/20160-117N/A-105N/A
12/31/20150-92N/A-81N/A
9/30/20150-57N/A-54N/A
6/30/20150-32N/A-28N/A
3/31/20150-22N/A-18N/A
12/31/20140-18N/A-14N/A
9/30/2014-3-12N/A-8N/A
6/30/2014-1-10N/A-7N/A
3/31/20140-9N/A-9N/A
12/31/20130-8N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRNA's forecast earnings growth (61.2% per year) is above the savings rate (2.4%).

Earnings vs Market: CRNA's earnings (61.2% per year) are forecast to grow faster than the Norwegian market (9.6% per year).

High Growth Earnings: CRNA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CRNA's revenue (110.5% per year) is forecast to grow faster than the Norwegian market (2.2% per year).

High Growth Revenue: CRNA's revenue (110.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CRNA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 05:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Circio Holding ASA is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arvid NecanderCarnegie Investment Bank AB
Geir HolomDNB Markets
Jonas PeciulisEdison Investment Research